Nichiban Co., Ltd. (NHBAF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nichiban Co., Ltd. (NHBAF) trades at $12.70 with AI Score 53/100 (Grade B). Nichiban Co. , Ltd. manufactures and sells medical products and tapes across Asia and Europe. Market cap: $258.54M, Sector: Industrials.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for NHBAF: NHBAF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NHBAF against Industrials peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
NHBAF: 2/6 perspectives are bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Nichiban Co., Ltd. (NHBAF) Industrial Operations Profile
Nichiban Co., Ltd., founded in 1918, is a Japanese manufacturer and distributor of medical products and various tape solutions, including surgical, OTC, stationery, and industrial tapes, with a presence in Asia and Europe and a market capitalization of $258.54M.
What Is the Investment Thesis for NHBAF?
Nichiban Co., Ltd. presents a stable investment profile within the industrials sector, characterized by its diversified product range and established presence in Asia and Europe. The company's modest profit margin of 3.1% and gross margin of 29.5% suggest opportunities for operational improvements. A dividend yield of 1.83% provides a steady income stream for investors. The low beta of 0.20 indicates lower volatility compared to the broader market. Growth catalysts include expanding into new geographic markets and developing innovative tape solutions. Potential risks include fluctuating raw material costs and increasing competition from global tape manufacturers. The company's P/E ratio of 25.02 reflects its current valuation relative to earnings.
Based on FMP financials and quantitative analysis
NHBAF Key Highlights
- Market capitalization of $258.54M, reflecting the company's current market value.
- P/E ratio of 25.02, indicating the price investors are willing to pay for each dollar of earnings.
- Profit margin of 3.1%, showcasing the company's profitability after all expenses.
- Gross margin of 29.5%, representing the percentage of revenue exceeding the cost of goods sold.
- Dividend yield of 1.83%, providing a return to investors through dividend payments.
Who Are NHBAF's Competitors?
NHBAF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALFNF Alfen N.V. | $11.15 | +1.36% | $242.43M | 35 |
| DMCHY DMCI Holdings, Inc. | $1.45 | +0.00% | $192.52M | 45 |
| MBRFF Mo-BRUK S.A. | $75.00 | +8.30% | $263.47M | 45 |
| NVNXF Novonix Limited | $0.12 | -2.32% | $87.35M | 54 |
| PCELF PowerCell Sweden AB (publ) | $1.91 | +0.00% | $110.57M | 53 |
| ACCL Acco Group Holdings Limited, based in Hong Kong, | $1.74 | +1.16% | $24.27M | 63 |
| BRTHF Brother Industries, Ltd. | $21.50 | -0.05% | $5.35B | 56 |
| HNI HNI Corporation | $41.36 | -0.17% | $2.24B | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NHBAF's Key Strengths?
- Diversified product portfolio.
- Established presence in Asia and Europe.
- Strong brand reputation in Japan.
- Low beta indicating lower volatility.
What Are NHBAF's Weaknesses?
- Relatively low profit margin.
- Limited geographic presence outside Asia and Europe.
- Dependence on raw material costs.
- Modest market capitalization.
What Could Drive NHBAF Stock Higher?
- Potential expansion into new geographic markets in Southeast Asia by Q4 2026.
- Continued investment in research and development for innovative tape solutions.
- Strengthening of e-commerce and digital marketing efforts to drive online sales.
What Are the Key Risks for NHBAF?
- Fluctuations in raw material costs affecting profitability.
- Increasing competition from global tape manufacturers.
- Economic downturns affecting industrial demand.
- Regulatory changes in healthcare and environmental standards.
What Are the Growth Opportunities for NHBAF?
- Expansion into Emerging Markets: Nichiban can pursue growth by expanding its presence in emerging markets across Asia and Latin America. These regions exhibit increasing demand for medical and industrial tapes, driven by growing healthcare sectors and industrialization. A targeted market entry strategy, focusing on localized product offerings and distribution networks, could significantly boost revenue. The global market for adhesive tapes in emerging economies is projected to grow at a CAGR of 5-7% over the next five years.
- Development of Innovative Tape Solutions: Investing in research and development to create innovative tape solutions for specialized applications can drive growth. This includes developing advanced medical tapes with enhanced adhesive properties, eco-friendly industrial tapes, and smart tapes with sensor technology. Collaborating with research institutions and industry partners can accelerate the innovation process. The market for specialized tapes is expanding, with applications in electronics, aerospace, and renewable energy sectors.
- Strategic Acquisitions and Partnerships: Nichiban can pursue strategic acquisitions and partnerships to expand its product portfolio and geographic reach. Acquiring smaller tape manufacturers with complementary product lines or entering into partnerships with distributors in new markets can accelerate growth. Identifying synergistic opportunities and conducting thorough due diligence are crucial for successful acquisitions and partnerships. The M&A activity in the tape and adhesive industry remains robust, with numerous opportunities for consolidation.
- Enhancing E-commerce and Digital Marketing: Strengthening its e-commerce presence and digital marketing efforts can help Nichiban reach a broader customer base and drive online sales. Investing in a user-friendly online platform, optimizing search engine visibility, and leveraging social media marketing can enhance brand awareness and generate leads. The e-commerce channel for tapes and adhesive products is experiencing rapid growth, driven by convenience and accessibility.
- Focus on Sustainable and Eco-Friendly Products: Developing and promoting sustainable and eco-friendly tape products can appeal to environmentally conscious customers and gain a competitive advantage. This includes using bio-based materials, reducing waste in manufacturing processes, and offering recyclable or biodegradable tape options. The demand for sustainable products is growing across various industries, driven by consumer preferences and regulatory requirements.
What Opportunities Does NHBAF Have?
- Expansion into emerging markets.
- Development of innovative tape solutions.
- Strategic acquisitions and partnerships.
- Enhancing e-commerce and digital marketing.
What Threats Does NHBAF Face?
- Increasing competition from global tape manufacturers.
- Fluctuations in raw material costs.
- Economic downturns affecting industrial demand.
- Regulatory changes in healthcare and environmental standards.
What Are NHBAF's Competitive Advantages?
- Established brand reputation in the Japanese market.
- Diversified product portfolio across medical, OTC, and industrial segments.
- Distribution network in Asia and Europe.
- Focus on specialized tape solutions for niche applications.
What Does NHBAF Do?
Nichiban Co., Ltd., established in 1918 and headquartered in Tokyo, Japan, has evolved into a diversified manufacturer and distributor of medical products and tape solutions. Initially focused on adhesive tapes, the company expanded its product lines to include medical products, OTC offerings, stationery, and specialized industrial tapes. Nichiban's medical products range from surgical tapes and first-aid bandages to hemostatic bandages, catering to healthcare professionals and consumers. Their OTC products include anti-inflammatory patches and foot care solutions. The company's taping tapes cover cotton, elastic, and kinesiology applications, while their stationery products include cellulose and double-sided tapes. Nichiban also provides industrial tapes for packaging, agriculture, and automotive applications. With a presence in Asia and Europe, Nichiban serves a broad customer base across various sectors, maintaining a competitive position through its diversified product portfolio and established brand reputation.
What Products and Services Does NHBAF Offer?
- Manufactures and sells surgical tapes for medical applications.
- Produces first-aid bandages and hemostatic bandages for wound care.
- Offers anti-inflammatory patches and foot care products for OTC markets.
- Provides cotton, elastic, and kinesiology taping tapes for sports and rehabilitation.
- Manufactures cellulose and double-sided tapes for stationery purposes.
- Supplies industrial tapes for packaging, agriculture, and automotive applications.
- Offers specialized tapes for various industrial and commercial uses.
How Does NHBAF Make Money?
- Manufacturing and distribution of medical products and tapes.
- Sales through direct channels, distributors, and retailers.
- Revenue generation from a diversified product portfolio.
- Focus on serving both consumer and industrial markets.
What Industry Does NHBAF Operate In?
Nichiban Co., Ltd. operates within the business equipment and supplies industry, which is characterized by steady growth and demand for specialized products. The global adhesive tapes market is projected to reach billions of dollars by 2026, driven by increasing applications in packaging, healthcare, and automotive sectors. Competition includes companies like ALFNF (Alfen N.V.), DMCHY (DIC Corporation), and MBRFF (Nitto Denko Corporation), which offer similar products. Nichiban's diversified product portfolio and established presence in Asia and Europe position it to capture a share of this growing market.
Who Are NHBAF's Key Customers?
- Healthcare professionals and hospitals.
- Retail consumers seeking first-aid and OTC products.
- Athletes and sports medicine professionals.
- Businesses in packaging, agriculture, and automotive industries.
How Nichiban Co., Ltd. Is Valued
Nichiban Co., Ltd. carries a market capitalization of $258.54M, placing it in the micro-cap category. Relative to its peer group, NHBAF's quantitative score of 53/100 is roughly in line with the peer average of 46/100.
Company Profile
Nichiban Co., Ltd. operates in the Business Equipment & Supplies industry within the Industrials sector. It is headquartered in Tokyo, JP. The company is led by CEO Toshiaki Takatsu. NHBAF has traded publicly since 2020.
ROE 4%Key Financial Metrics
Return on equity for Nichiban Co., Ltd. stands at 3.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.5%, showing how much profit it generates from its asset base. NHBAF trades at a trailing price-to-earnings ratio of 23.28, below the Industrials sector average of ~30x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.28 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.3%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 6/9Financial Health
Nichiban Co., Ltd.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.94 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project Nichiban Co., Ltd. revenue of about $51.05B for fiscal 2026, with EPS near $0.00.
NHBAF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Diversified product portfolio.
- Established presence in Asia and Europe.
- Strong brand reputation in Japan.
- Low beta indicating lower volatility.
Bear Case
- Relatively low profit margin.
- Limited geographic presence outside Asia and Europe.
- Dependence on raw material costs.
- Modest market capitalization.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
NHBAF Latest News
No recent news available for NHBAF.
NHBAF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NHBAF.
Price Targets
Wall Street price target analysis for NHBAF.
NHBAF MoonshotScore
What does this score mean?
The MoonshotScore rates NHBAF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Business Equipment & SuppliesLeadership: Toshiaki Takatsu
CEO
Toshiaki Takatsu serves as the CEO of Nichiban Co., Ltd., overseeing the company's operations and strategic direction. His background includes extensive experience in the manufacturing and distribution of medical products and tape solutions. Prior to his role as CEO, Takatsu held various leadership positions within Nichiban, contributing to the company's growth and expansion. He is responsible for managing a workforce of 1270 employees and driving innovation across the company's product lines.
Track Record: Under Toshiaki Takatsu's leadership, Nichiban Co., Ltd. has focused on expanding its presence in key markets and developing innovative tape solutions. Key achievements include strengthening the company's e-commerce presence and driving growth in the medical products segment. Takatsu has also emphasized sustainability initiatives, focusing on developing eco-friendly tape options. His strategic decisions have contributed to maintaining Nichiban's competitive position in the industry.
NHBAF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Nichiban Co., Ltd. may not meet the minimum financial or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as exchange-listed companies. Investing in OTC Other stocks carries higher risks due to the potential for limited information and liquidity compared to stocks listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure requirements.
- Potential for lower trading volume and liquidity.
- Wider bid-ask spreads.
- Higher price volatility.
- Risk of fraud or manipulation.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Check for any regulatory actions or legal issues.
- Monitor trading volume and price activity.
- Consult with a financial advisor.
- Established operating history since 1918.
- Diversified product portfolio across multiple segments.
- Presence in Asia and Europe.
- Management team with industry experience.
- Dividend payments to shareholders.
What Investors Ask About Nichiban Co., Ltd. (NHBAF) — Industrials
What does Nichiban Co., Ltd. do?
Nichiban Co., Ltd. is a manufacturer and distributor of medical products and tape solutions. The company's product portfolio includes surgical tapes, first-aid bandages, anti-inflammatory patches, and various industrial and stationery tapes. Nichiban serves a diverse customer base across healthcare, retail, and industrial sectors, with a presence in Asia and Europe. The company's business model focuses on manufacturing quality products and distributing them through direct channels, distributors, and retailers.
What do analysts say about NHBAF stock?
As of March 18, 2026, there is no readily available analyst coverage for NHBAF stock due to its OTC listing. Investors should conduct their own due diligence and consider the company's financial performance, growth opportunities, and risk factors. Key valuation metrics include the P/E ratio of 25.02 and dividend yield of 1.83%. Growth considerations include expanding into new markets and developing innovative products. The company's modest profit margin of 3.1% warrants monitoring for potential improvements.
What are the main risks for NHBAF?
The main risks for Nichiban Co., Ltd. include fluctuations in raw material costs, increasing competition from global tape manufacturers, economic downturns affecting industrial demand, and regulatory changes in healthcare and environmental standards. As an OTC-listed company, NHBAF also faces risks related to limited financial disclosure, lower trading volume, and potential price volatility. Investors should carefully assess these risks before investing in NHBAF stock.
What are the key factors to evaluate for NHBAF?
Nichiban Co., Ltd. (NHBAF) holds an AI score of 53/100 (moderate). Not financial advice.
How frequently does NHBAF data refresh on this page?
NHBAF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NHBAF's recent stock price performance?
Nichiban Co., Ltd. (NHBAF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NHBAF overvalued or undervalued right now?
Valuing Nichiban Co., Ltd. (NHBAF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NHBAF?
Before investing in Nichiban Co., Ltd. (NHBAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited.
- AI analysis is pending for NHBAF.